Orchard Therapeutics: Gene Therapy For Rare Child Disease (NASDAQ:ORTX)
Orchard Therapeutics has become interesting after its 78% dip plus the fact that a large investment fund quadrupled its position in the stock.
Source: seekingalpha.com
Page 35 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharming Group Today - Breaking & Trending Today
Pharming Group N.V.: Pharming Group reports financial results for the first half of 2022
Total revenues increased 4% in H1 2022 to US$96.8 million, supported by increases in physicians prescribing and number of patients Strong balance sheet and stable cash flow from RUCONEST providing
Source: finanznachrichten.de
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that a new diagnosis code for reporting...
Source: prnewswire.com
Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agency's...
Source: prnewswire.com
Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agency's...
Source: prnewswire.com